Ken Griffin’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.6M | Sell |
1,406,352
-39,643
| -3% | -$2.02M | 0.01% | 396 |
|
|
2025
Q1 | $65.1M | Sell |
1,445,995
-65,188
| -4% | -$2.94M | 0.01% | 380 |
|
|
2024
Q4 | $62.5M | Buy |
1,511,183
+119,774
| +9% | +$4.95M | 0.01% | 443 |
|
|
2024
Q3 | $54.3M | Sell |
1,391,409
-194,215
| -12% | -$7.57M | 0.01% | 438 |
|
|
2024
Q2 | $54.2M | Buy |
1,585,624
+193,118
| +14% | +$6.6M | 0.01% | 445 |
|
|
2024
Q1 | $35M | Sell |
1,392,506
-50,306
| -3% | -$1.26M | 0.01% | 617 |
|
|
2023
Q4 | $42.6M | Sell |
1,442,812
-274,445
| -16% | -$8.1M | 0.01% | 527 |
|
|
2023
Q3 | $53.7M | Buy |
1,717,257
+287,412
| +20% | +$8.98M | 0.01% | 405 |
|
|
2023
Q2 | $37M | Buy |
1,429,845
+60,500
| +4% | +$1.57M | 0.01% | 537 |
|
|
2023
Q1 | $32.9M | Sell |
1,369,345
-39,214
| -3% | -$942K | 0.01% | 617 |
|
|
2022
Q4 | $27.5M | Buy |
1,408,559
+483,382
| +52% | +$9.43M | 0.01% | 713 |
|
|
2022
Q3 | $19.4M | Buy |
925,177
+495,330
| +115% | +$10.4M | ﹤0.01% | 842 |
|
|
2022
Q2 | $8.37M | Buy |
429,847
+96,819
| +29% | +$1.88M | ﹤0.01% | 1412 |
|
|
2022
Q1 | $7.33M | Buy |
333,028
+206,602
| +163% | +$4.55M | ﹤0.01% | 1700 |
|
|
2021
Q4 | $2.02M | Buy |
126,426
+39,948
| +46% | +$637K | ﹤0.01% | 3050 |
|
|
2021
Q3 | $1.72M | Buy |
+86,478
| New | +$1.72M | ﹤0.01% | 3179 |
|
|
2021
Q1 | – | Sell |
-15,437
| Closed | -$269K | – | 6619 |
|
|
2020
Q4 | $269K | Sell |
15,437
-11,442
| -43% | -$199K | ﹤0.01% | 4310 |
|
|
2020
Q3 | $518K | Buy |
26,879
+13,742
| +105% | +$265K | ﹤0.01% | 3472 |
|
|
2020
Q2 | $256K | Buy |
+13,137
| New | +$256K | ﹤0.01% | 3918 |
|